CY1108619T1 - Πρωτεϊνη σπονδυλωτων patched-2 - Google Patents

Πρωτεϊνη σπονδυλωτων patched-2

Info

Publication number
CY1108619T1
CY1108619T1 CY20081101409T CY081101409T CY1108619T1 CY 1108619 T1 CY1108619 T1 CY 1108619T1 CY 20081101409 T CY20081101409 T CY 20081101409T CY 081101409 T CY081101409 T CY 081101409T CY 1108619 T1 CY1108619 T1 CY 1108619T1
Authority
CY
Cyprus
Prior art keywords
patched
temperature protein
protein
temperature
immunoadhesins
Prior art date
Application number
CY20081101409T
Other languages
Greek (el)
English (en)
Inventor
Sauvage Frederic J De
David A Carpenter
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22032676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108619(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1108619T1 publication Critical patent/CY1108619T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
CY20081101409T 1998-04-15 2008-12-03 Πρωτεϊνη σπονδυλωτων patched-2 CY1108619T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/060,939 US6709838B1 (en) 1998-04-15 1998-04-15 Nucleic acid encoding patched-2
EP99945688A EP1071779B1 (en) 1998-04-15 1999-04-02 Vertebrate patched-2 protein

Publications (1)

Publication Number Publication Date
CY1108619T1 true CY1108619T1 (el) 2014-04-09

Family

ID=22032676

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101409T CY1108619T1 (el) 1998-04-15 2008-12-03 Πρωτεϊνη σπονδυλωτων patched-2

Country Status (13)

Country Link
US (1) US6709838B1 (enExample)
EP (1) EP1071779B1 (enExample)
JP (2) JP4693237B2 (enExample)
AT (1) ATE410513T1 (enExample)
AU (1) AU765918B2 (enExample)
CA (1) CA2323572C (enExample)
CY (1) CY1108619T1 (enExample)
DE (1) DE69939694D1 (enExample)
DK (1) DK1071779T3 (enExample)
ES (1) ES2316192T3 (enExample)
IL (3) IL138585A0 (enExample)
PT (1) PT1071779E (enExample)
WO (1) WO1999053058A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1716599A (en) * 1997-12-08 1999-06-28 Curis, Inc. Human patched genes and proteins, and uses related thereto
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway
GB9908798D0 (en) * 1999-04-16 1999-06-09 Pharmacia & Upjohn Spa Human homologues of fused gene
WO2001041786A1 (en) * 1999-12-10 2001-06-14 The General Hospital Corporation METHODS TO STIMULATE INSULIN PRODUCTION BY PANCREATIC β-CELLS
SE0000345D0 (sv) * 2000-02-03 2000-02-03 Karolinska Innovations Ab New matter
EP1229046A3 (en) * 2001-01-30 2004-02-25 Aeomica, Inc. Human testis expressed patched like protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
CA2179029C (en) 1993-12-30 2009-02-24 Philip W. Ingham Vertebrate embryonic pattern-inducing hedgehog-like proteins
DE69534310T2 (de) 1994-10-07 2006-04-27 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Ptc gene und ihre verwendung
US6027882A (en) 1994-10-07 2000-02-22 The Regents Of The University Of California Patched genes and their use for diagnostics
US6051400A (en) 1997-05-23 2000-04-18 Smithkline Beecham Plc Patched-2 polypeptides and polynucleotides
AU1716599A (en) 1997-12-08 1999-06-28 Curis, Inc. Human patched genes and proteins, and uses related thereto
US6022708A (en) 1998-02-26 2000-02-08 Genentech, Inc. Fused
SE9803393D0 (sv) * 1998-10-06 1998-10-06 Karolinska Innovations Ab A novel component in the hedgehog signalling pathway

Also Published As

Publication number Publication date
CA2323572A1 (en) 1999-10-21
EP1071779B1 (en) 2008-10-08
PT1071779E (pt) 2009-01-13
DK1071779T3 (da) 2009-02-16
JP2002511263A (ja) 2002-04-16
CA2323572C (en) 2011-10-18
AU5265799A (en) 1999-11-01
WO1999053058A1 (en) 1999-10-21
IL138585A0 (en) 2001-10-31
AU765918B2 (en) 2003-10-02
IL138585A (en) 2010-11-30
DE69939694D1 (de) 2008-11-20
EP1071779A1 (en) 2001-01-31
US6709838B1 (en) 2004-03-23
ATE410513T1 (de) 2008-10-15
IL205793A (en) 2015-01-29
JP2010046077A (ja) 2010-03-04
JP4693237B2 (ja) 2011-06-01
ES2316192T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
ZA991525B (en) Vertebrate fused.
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
CY1108619T1 (el) Πρωτεϊνη σπονδυλωτων patched-2
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
DK1064376T3 (da) GFR-alpha3 og dets anvendelser
WO1999027098A3 (en) A-33 related antigens and their pharmacological uses
DE69535696D1 (de) Tripeptidyl-aminopeptidase
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
EP1117779A4 (en) -i (MORAXELLA CATARRHALIS) PrPTEIN; NUCLEAR SAUCE SEQUENCE AND APPLICATIONS
ATE443761T1 (de) Rtd receptor
ATE317896T1 (de) Polypeptide mit glucanotransferase aktivität und dafür kodierende nukleinsäuren
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
ATE408687T1 (de) Semaphorin polypeptide
WO2003087331A3 (en) Polyvalent cation-sensing receptor in atlantic salmon
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
WO1999043829A3 (en) Cell cycle related proteins
WO2000065025A3 (en) Dna molecules encoding human endothelin converting enzyme 3
WO2001040461A3 (de) cDNA-SEQUENZEN VON ZWEI INTERAKTOREN FANCIP4 UND FANCIP5 DER FANCONI-ANÄMIE-PROTEINE DER KOMPLEMENTATIONSGRUPPEN A UND C
ECSP993285A (es) Sintesis recombinante de beta lipotropina y otros peptidos
CO5400145A1 (es) Proteina asociada con enfermedad
TH34378A (th) ลำดับกรดนูคลีอิคที่ยับยั้งทรานสคริปชั่น และปัจจัยที่ทำให้มีการจับของมัน